Net income increased 33.8%
Net income changed +33.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +33.8% from the comparable as-filed period.
Free-cash-flow proxy changed -366.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash flow changed -343.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash-flow margin changed -1093 basis points from the comparable as-filed period.
Revenue changed +12.4% from the comparable as-filed period.
Gross margin changed +31 basis points from the comparable as-filed period.
Free-cash-flow margin changed -1094 basis points from the comparable as-filed period.
Total assets changed +12.5% from the comparable as-filed period.
Gross profit changed +14.3% from the comparable as-filed period.
Working capital changed +9.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed +19.2% from the comparable as-filed period.
Shares outstanding changed -0.6% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
Receivables / revenue changed +125 basis points from the comparable as-filed period.
Working capital / assets changed -155 basis points from the comparable as-filed period.
SBC / revenue changed -1 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow / net income changed -281.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Stock-based compensation changed +7.8% from the comparable as-filed period.
Selling, general & administrative changed +7.1% from the comparable as-filed period.
Current ratio changed -6.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed +1 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.